Kisspeptin is a family of RF-amide neuropeptides encoded by the KISS1 gene that bind the G protein-coupled receptor KISS1R (originally GPR54), and in laboratory models this ligand-receptor pair sits upstream of gonadotropin-releasing hormone (GnRH) neurons as one of the most-studied control points of the hypothalamic-pituitary-gonadal (HPG) axis. Kisspeptin-10 — the decapeptide YNWNSFGLRF-NH2 (CAS 374675-21-5; molecular weight ≈1302.45 g/mol) — is the shortest fully active fragment and the form most commonly used as a reference agonist in receptor and neuroendocrine assays. This article summarizes the discovery history, receptor pharmacology, mechanistic literature, and handling guidance for kisspeptin as a research compound. All information is provided strictly for in-vitro and laboratory research use only.
What Is Kisspeptin?
KISS1 was first characterized as a metastasis-suppressor gene, which is why its peptide products carry the somewhat unusual "kiss" naming. The gene encodes a 145-amino-acid precursor that is proteolytically processed into several C-terminally amidated fragments sharing a common RF-amide (Arg-Phe-NH2) terminus: kisspeptin-54 (originally isolated and named metastin), kisspeptin-14, kisspeptin-13, and kisspeptin-10. All four fragments correspond to the same C-terminal region of the precursor, and all four activate KISS1R with comparable potency in cell-based assays — the shared C-terminal decapeptide is the minimal pharmacophore.
Kisspeptin-10 is therefore the compact, chemically tractable version of the endogenous signal. Its ten residues (Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2, human sequence) are what most structure-activity and receptor-binding work is built around, and it is the sequence supplied here as a lyophilized research compound.
As a freshness marker for readers tracking the field: a May 2025 review in the International Journal of Molecular Sciences, authored by investigators at the NIH's National Center for Advancing Translational Sciences and NIEHS, surveyed current screening technologies for identifying KISS1R agonists and antagonists and catalogued the state of ligand discovery around this receptor. As of 2026 the kisspeptin/KISS1R system remains an active target for chemical-biology and assay-development work, which is a large part of why the reference peptide continues to be used in laboratories.
Discovery and the Genetic Evidence
The kisspeptin literature has an unusually clean origin story, and it is worth understanding because it explains why the peptide became a standard laboratory tool so quickly.
Deorphanization of GPR54 (2001)
Two groups independently identified KISS1-derived peptides as the endogenous ligands of the orphan receptor GPR54 in 2001. Ohtaki and colleagues, publishing in Nature, isolated a 54-residue C-terminally amidated peptide from human placenta as the ligand of the orphan receptor hOT7T175 and named it metastin, reporting that it inhibited chemotaxis and invasion of GPR54-transfected CHO cells in vitro and attenuated pulmonary metastasis of GPR54-transfected B16-BL6 melanoma cells in vivo. In parallel, Kotani and colleagues, publishing in the Journal of Biological Chemistry, isolated 54-, 14-, and 13-residue RF-amide peptides from human placenta, named them kisspeptins, and characterized their pharmacology: low-nanomolar binding affinity at rat and human GPR54 expressed in CHO-K1 cells, with agonist activity producing PIP2 hydrolysis, calcium mobilization, arachidonic acid release, ERK1/2 and p38 MAP-kinase phosphorylation, and stress-fiber formation, alongside inhibition of cell proliferation. That paper also mapped human GPR54 expression to placenta, pituitary, pancreas, and spinal cord.
The 2003 human genetics (the reason the field exploded)
The reproductive role of the system was established not by pharmacology but by human genetics. In 2003, de Roux and colleagues reported in PNAS that loss-of-function of GPR54 causes isolated hypogonadotropic hypogonadism, identified via homozygosity whole-genome mapping in a large consanguineous family with five affected siblings and a normal GnRH receptor coding sequence, localizing a new locus to chromosome 19p13. In the same year, Seminara and colleagues reported in the New England Journal of Medicine that mutations in GPR54 cause autosomal recessive idiopathic hypogonadotropic hypogonadism in both humans and mice, concluding that the receptor is required for normal GnRH physiology and for pubertal onset.
The convergence of two independent human genetics studies with mouse knockout data made KISS1R a rare case of a receptor whose necessity in a physiological system was demonstrated before its ligand was widely available. Kisspeptin-10 became the standard agonist for probing it.
Mechanism of Action
KISS1R is a Gq/11-coupled GPCR
KISS1R signals principally through Gq/11, activating phospholipase C-beta, hydrolyzing PIP2 to IP3 and diacylglycerol, releasing intracellular calcium, and engaging PKC and the ERK1/2 and p38 MAP-kinase cascades. In GnRH-neuron models, this depolarizes the cell through activation of nonselective cation conductances and inhibition of inwardly rectifying potassium currents — the electrophysiological basis for kisspeptin's potency as a GnRH-neuron stimulus in slice preparations. Because the response is robust and readily quantified by calcium flux, inositol-phosphate accumulation, or beta-arrestin recruitment, kisspeptin-10 is frequently used as the positive-control agonist when validating KISS1R assays.
KNDy neurons and pulse generation
The more interesting systems-level question is how a tonic peptide signal produces the episodic GnRH release that defines reproductive endocrinology. The prevailing model in the literature centers on KNDy neurons — a population in the hypothalamic arcuate nucleus that co-expresses kisspeptin, neurokinin B (NKB), and dynorphin A. In this model, kisspeptin is the output signal that drives GnRH release, while NKB and dynorphin act as reciprocal start and stop signals within a recurrently interconnected KNDy network, synchronizing and then terminating population activity to generate discrete pulses.
Lehman, Coolen, and Goodman laid out this framework in a 2010 Endocrinology minireview describing arcuate KNDy cells as a central node in the control of GnRH secretion, noting that these cells form a reciprocally interconnected network with direct projections to GnRH cell bodies and terminals and are positioned to convey steroid feedback to the GnRH system. Uenoyama and colleagues reviewed the accumulated evidence in Frontiers in Endocrinology in 2021, describing KNDy neurons across rodents, ruminants, and primates as largely responsible for GnRH pulse generation. A separate hypothalamic population in the anteroventral periventricular (AVPV) region is generally associated with the surge mode rather than the pulsatile mode in rodent models.
The metastasis-suppressor thread
Running alongside the reproductive literature is the original oncology thread. Because KISS1 was identified as a metastasis suppressor and Kotani's work found KISS1R activation to inhibit proliferation in transfected cells, kisspeptin signaling has continued to be examined in tumor-biology models. That literature is genuinely mixed — reports of both suppressive and permissive effects appear depending on tumor type and model system — and reviews have described the role of kisspeptin/KISS1R in tumor development as controversial rather than settled. Researchers using kisspeptin-10 in cancer cell lines should treat the direction of effect as an open experimental question rather than an assumption.
Published Research Overview
The peer-reviewed literature most relevant to laboratory use of kisspeptin-10 clusters into four areas:
- Receptor deorphanization and pharmacology. Kotani et al. (Journal of Biological Chemistry, 2001) established low-nanomolar binding of kisspeptins at rat and human GPR54 and characterized the downstream Gq-linked signaling profile in CHO-K1 cells. Ohtaki et al. (Nature, 2001) independently identified the 54-residue peptide as the GPR54 ligand and reported anti-metastatic effects in transfected cell and mouse models.
- Genetic necessity in the HPG axis. de Roux et al. (PNAS, 2003) and Seminara et al. (New England Journal of Medicine, 2003) independently established that GPR54 loss-of-function produces hypogonadotropic hypogonadism, with concordant mouse knockout data.
- Pulse-generator neurobiology. Lehman et al. (Endocrinology, 2010) and Uenoyama et al. (Frontiers in Endocrinology, 2021) synthesize the KNDy model of episodic GnRH secretion and the anatomical evidence supporting it across species.
- Current ligand discovery. Chen et al. (International Journal of Molecular Sciences, 2025) review screening technologies and the current landscape of KISS1R agonists and antagonists, including the challenges in developing ligands with useful selectivity and stability profiles.
Storage & Handling
Dynamite Research Peptides supplies kisspeptin-10 as a lyophilized (freeze-dried) powder at 99%+ purity, with a stated shelf life of approximately two years when stored properly. Store the lyophilized powder at -20°C, protected from light and moisture. Reconstitute immediately before use with a sterile solvent as indicated on the Certificate of Analysis (COA).
A practical note specific to this sequence: kisspeptin-10 is a short, C-terminally amidated peptide containing an oxidation-sensitive tryptophan residue, and it is subject to rapid proteolytic degradation in biological matrices. Keep reconstituted stocks refrigerated, aliquot to avoid repeated freeze-thaw cycles, and prepare working dilutions fresh — degradation is a common and under-recognized source of variability in KISS1R potency measurements. Handle with appropriate personal protective equipment in a well-ventilated laboratory setting.
Conclusion
Kisspeptin-10 is the minimal active fragment of the KISS1 gene product and the standard reference agonist for KISS1R/GPR54 — a receptor whose necessity in reproductive neuroendocrinology was established by convergent human genetics and mouse knockout evidence, and which remains an active target in current ligand-discovery work. Our kisspeptin is high-purity, third-party tested, and ships with a COA so experimental results stay reliable and reproducible.
Frequently Asked Questions
What is kisspeptin?
Kisspeptin refers to a family of C-terminally amidated RF-amide peptides produced from the KISS1 gene precursor — kisspeptin-54, -14, -13, and -10 — that act as endogenous agonists at the receptor KISS1R (GPR54).
What is the difference between kisspeptin-10 and kisspeptin-54?
They are different-length fragments of the same precursor sharing an identical C-terminal decapeptide, which is the minimal region required for receptor activation. In cell-based assays both activate KISS1R with comparable potency; kisspeptin-54 was the fragment originally isolated from placenta and named metastin, while kisspeptin-10 is the shorter, more chemically tractable form used in most laboratory work.
What receptor does kisspeptin act on?
KISS1R, formerly the orphan receptor GPR54 (also called hOT7T175 and AXOR12 in early literature). It is a Gq/11-coupled GPCR that signals through phospholipase C, calcium mobilization, PKC, and the ERK1/2 and p38 MAP-kinase pathways.
What are KNDy neurons?
KNDy neurons are arcuate-nucleus cells co-expressing kisspeptin, neurokinin B, and dynorphin A. In the prevailing model of GnRH pulse generation, kisspeptin provides the output signal while NKB and dynorphin act as start and stop signals that synchronize and terminate network activity.
Why was KISS1 originally called a metastasis suppressor gene?
KISS1 was first identified through its suppression of metastatic behavior in melanoma cells, before its peptide products were known to be GPR54 ligands. The reproductive function of the system was discovered later, in 2003.
What is the purity level of Dynamite Research Peptides' kisspeptin?
Our kisspeptin-10 is typically 99%+ pure, verified by HPLC analysis. Detailed purity data is provided on the Certificate of Analysis (COA) included with each product.
What research applications is kisspeptin suitable for?
It is used as a reference KISS1R agonist in receptor binding and functional assays, in studies of GnRH neuronal signaling and HPG axis regulation in tissue and slice preparations, and in in-vitro investigations of KISS1R expression and downstream signaling in other cell types.
All products are for research use only — not for human or animal consumption, and not for diagnostic or therapeutic use. Last updated: July 20, 2026.